Drug shortage
Extended Release · Noven Pharmaceuticals, Inc.
FDA drug shortage · Current · updated Mar 4, 2025
Key facts
| Generic name | Extended Release, Methylphenidate Film |
|---|---|
| Proprietary name | Daytrana |
| Company | Noven Pharmaceuticals, Inc. |
| Presentation | Daytrana, Film, Extended Release, 20 mg (NDC 68968-5554-3) |
| Dosage form | Extended Release, Film |
| Strength | 20 mg |
| Status | Current |
| Reason for shortage | Shortage of an active ingredient |
| Therapeutic category | Psychiatry |
| Package NDCs | 68968-5554-3 |
| First posted | Feb 28, 2025 |
| Last updated | Mar 4, 2025 |
At a glance
- 1–9 Package NDCs affected
- 100–999 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: